Kohei Hasegawa1, Koichiro Gibo2, Yusuke Tsugawa3, Yuichi J Shimada4, Carlos A Camargo5. 1. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address: khasegawa1@partners.org. 2. Biostatistics Center, Kurume University, Kurume, Fukuoka, Japan. 3. Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA. 4. Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 5. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Abstract
BACKGROUND: Reducing hospital readmissions has attracted attention from many stakeholders. However, the characteristics of 30-day readmissions after asthma-related hospital admissions in adults are not known. It is also unclear whether older adults are at higher risk of 30-day readmission. OBJECTIVES: To investigate the rate, timing, and principal diagnosis of 30-day readmissions in adults with asthma and to determine age-related differences. METHODS: Retrospective cohort study of adults hospitalized for asthma exacerbation using the population-based inpatient samples of three states (California, Florida, and Nebraska) from 2005 through 2011. Patients were categorized into three age groups: younger (18-39 years), middle aged (40-64 years), and older (≥ 65 years) adults. Outcomes were 30-day all-cause readmission rate, timing, and principal diagnosis of readmission. RESULTS: Of 301,164 asthma-related admissions at risk for 30-day readmission, readmission rate was 14.5%. Compared with younger adults, older adults had significantly higher readmission rates (10.1% vs 16.5%; OR, 2.15 [95% CI, 2.07-2.23]; P < .001). The higher rate attenuated with adjustment (OR, 1.19 [95% CI, 1.13-1.26]; P < .001), indicating that most of the age-related difference is explained by sociodemographics and comorbidities. For all age groups, readmission rate was highest in the first week after discharge and declined thereafter. Overall, only 47.1% of readmissions were assigned respiratory diagnoses (asthma, COPD, pneumonia, and respiratory failure). Older adults were more likely to present with nonrespiratory diagnoses (41.7% vs 53.8%; P < .001). CONCLUSIONS: After asthma-related admission, 14.5% of patients had 30-day readmission with wide range of principal diagnoses. Compared with younger adults, older adults had higher 30-day readmission rates and proportions of nonrespiratory diagnoses.
BACKGROUND: Reducing hospital readmissions has attracted attention from many stakeholders. However, the characteristics of 30-day readmissions after asthma-related hospital admissions in adults are not known. It is also unclear whether older adults are at higher risk of 30-day readmission. OBJECTIVES: To investigate the rate, timing, and principal diagnosis of 30-day readmissions in adults with asthma and to determine age-related differences. METHODS: Retrospective cohort study of adults hospitalized for asthma exacerbation using the population-based inpatient samples of three states (California, Florida, and Nebraska) from 2005 through 2011. Patients were categorized into three age groups: younger (18-39 years), middle aged (40-64 years), and older (≥ 65 years) adults. Outcomes were 30-day all-cause readmission rate, timing, and principal diagnosis of readmission. RESULTS: Of 301,164 asthma-related admissions at risk for 30-day readmission, readmission rate was 14.5%. Compared with younger adults, older adults had significantly higher readmission rates (10.1% vs 16.5%; OR, 2.15 [95% CI, 2.07-2.23]; P < .001). The higher rate attenuated with adjustment (OR, 1.19 [95% CI, 1.13-1.26]; P < .001), indicating that most of the age-related difference is explained by sociodemographics and comorbidities. For all age groups, readmission rate was highest in the first week after discharge and declined thereafter. Overall, only 47.1% of readmissions were assigned respiratory diagnoses (asthma, COPD, pneumonia, and respiratory failure). Older adults were more likely to present with nonrespiratory diagnoses (41.7% vs 53.8%; P < .001). CONCLUSIONS: After asthma-related admission, 14.5% of patients had 30-day readmission with wide range of principal diagnoses. Compared with younger adults, older adults had higher 30-day readmission rates and proportions of nonrespiratory diagnoses.
Authors: Kohei Hasegawa; Ashley F Sullivan; Eva Tovar Hirashima; Theodore J Gaeta; Christopher Fee; Stuart J Turner; Susan Massaro; Carlos A Camargo Journal: J Allergy Clin Immunol Pract Date: 2014-09-10
Authors: Kohei Hasegawa; Jane C Bittner; Stephanie A Nonas; Samantha J Stoll; Taketo Watase; Susan Gabriel; Vivian Herrera; Carlos A Camargo Journal: J Allergy Clin Immunol Pract Date: 2015-05-28
Authors: Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand Journal: Circ Cardiovasc Qual Outcomes Date: 2011-03
Authors: Mario Castro; Nina A Zimmermann; Sue Crocker; Joseph Bradley; Charles Leven; Kenneth B Schechtman Journal: Am J Respir Crit Care Med Date: 2003-06-13 Impact factor: 21.405
Authors: Tadahiro Goto; Mohammad Kamal Faridi; Koichiro Gibo; Sengwee Toh; Nicola A Hanania; Carlos A Camargo; Kohei Hasegawa Journal: Respir Med Date: 2017-07-26 Impact factor: 3.415
Authors: David T Huang; Donald M Yealy; Michael R Filbin; Aaron M Brown; Chung-Chou H Chang; Yohei Doi; Michael W Donnino; Jonathan Fine; Michael J Fine; Michelle A Fischer; John M Holst; Peter C Hou; John A Kellum; Feras Khan; Michael C Kurz; Shahram Lotfipour; Frank LoVecchio; Octavia M Peck-Palmer; Francis Pike; Heather Prunty; Robert L Sherwin; Lauren Southerland; Thomas Terndrup; Lisa A Weissfeld; Jonathan Yabes; Derek C Angus Journal: N Engl J Med Date: 2018-05-20 Impact factor: 91.245
Authors: Peng Zhang; Rocio Lopez; Amy H Attaway; Steve N Georas; Sumita B Khatri; Simon Abi-Saleh; Joe G Zein Journal: J Allergy Clin Immunol Pract Date: 2020-11-09
Authors: Jonathan M Feldman; Jacqueline Becker; Arushi Arora; Jesenya DeLeon; Tatiana Torres-Hernandez; Naomi Greenfield; Allyana Wiviott; Sunit Jariwala; Chang Shim; Alex D Federman; Juan P Wisnivesky Journal: Psychosom Med Date: 2021-09-01 Impact factor: 3.864
Authors: Hans-Peter Brunner-La Rocca; Carol J Peden; John Soong; Per Arne Holman; Maria Bogdanovskaya; Lorna Barclay Journal: PLoS One Date: 2020-06-30 Impact factor: 3.240
Authors: Peter Dunbar; Matt Hall; James C Gay; Clarissa Hoover; Jessica L Markham; Jessica L Bettenhausen; James M Perrin; Karen A Kuhlthau; Morgan Crossman; Brigid Garrity; Jay G Berry Journal: JAMA Netw Open Date: 2019-07-03
Authors: Marco Caminati; Andrea Vianello; Giorgio Ricci; Giuliana Festi; Roberto Bellamoli; Sofia Longhi; Mariangiola Crivellaro; Guido Marcer; Marco Monai; Margherita Andretta; Chiara Bovo; Gianenrico Senna Journal: World Allergy Organ J Date: 2019-07-03 Impact factor: 4.084
Authors: Marjan Kerkhof; Trung N Tran; Maarten van den Berge; Guy G Brusselle; Gokul Gopalan; Rupert C M Jones; Janwillem W H Kocks; Andrew Menzies-Gow; Javier Nuevo; Ian D Pavord; Sarang Rastogi; David B Price Journal: PLoS One Date: 2018-07-25 Impact factor: 3.240